| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.26e-06 | 29 | 247 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.38e-06 | 70 | 247 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 7.80e-06 | 23 | 247 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.07e-05 | 14 | 247 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | filamin binding | 2.59e-05 | 29 | 247 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.02e-05 | 49 | 247 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.77e-05 | 34 | 247 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | DAB2IP CEACAM5 PSG1 PSG4 CEACAM8 CEACAM6 ADCY8 PXN CACNA1B PTPRT PAWR | 6.43e-05 | 210 | 247 | 11 | GO:0019903 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDH17 TCHHL1 PCDH15 NID1 MEX3B CACNA1B HSPG2 PCDHGC4 PCDHGB6 ESYT1 PCDHAC2 PCDHA5 ADAMTS13 CBLB EDEM3 TGM2 CELSR1 PRF1 DLL3 PCDHGB4 DCHS1 CDH8 | 1.66e-04 | 749 | 247 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | DAB2IP AMER1 CEACAM5 PSG1 PSG4 BCAS3 CEACAM8 CEACAM6 ZCCHC14 ESYT1 TIRAP VPS13B ARHGAP33 | 1.66e-04 | 316 | 247 | 13 | GO:0035091 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.87e-04 | 73 | 247 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | phosphatase binding | DAB2IP CEACAM5 PSG1 PSG4 CEACAM8 CEACAM6 ADCY8 PXN CACNA1B PTPRT PAWR | 4.71e-04 | 264 | 247 | 11 | GO:0019902 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 5.04e-04 | 81 | 247 | 6 | GO:0016811 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | HDAC9 HDAC4 IRF2BP1 NOC2L PPP1R13L MIDEAS PARP10 NCOR1 PAWR HR | 5.90e-04 | 229 | 247 | 10 | GO:0003714 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 8.82e-04 | 90 | 247 | 6 | GO:0008028 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PSG1 PSG4 CEACAM8 CEACAM6 PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PTPN23 PCDHA5 PTPRT CELSR1 PCDHGB4 DCHS1 IGSF9B IGSF21 CDH8 | 9.66e-13 | 187 | 244 | 19 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PSG1 PSG4 CEACAM8 CEACAM6 PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PTPN23 PCDHA5 PTPRT CELSR1 ELFN1 PCDHGB4 DCHS1 IGSF9B IGSF21 CDH8 | 1.10e-09 | 313 | 244 | 20 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.18e-08 | 15 | 244 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 4.25e-08 | 18 | 244 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.08e-07 | 14 | 244 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.06e-07 | 15 | 244 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.73e-07 | 16 | 244 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.23e-06 | 17 | 244 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.23e-06 | 17 | 244 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.18e-06 | 33 | 244 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.98e-06 | 20 | 244 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.88e-06 | 21 | 244 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.97e-06 | 22 | 244 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.29e-06 | 23 | 244 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CEACAM5 PSG1 PSG4 RIPK2 CEACAM8 CEACAM6 SOCS6 PCDH17 PCDH15 ADAMTS18 PKP2 PLEKHA7 MEX3B PCDHGC4 PCDHGB6 PCDHAC2 PTPN23 PCDHA5 CBLB PTPRT CELSR1 ELFN1 PCDHGB4 DCHS1 SMARCA2 SMARCC2 PAWR IGSF9B IGSF21 CDH8 | 1.20e-05 | 1077 | 244 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.45e-05 | 27 | 244 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.47e-05 | 93 | 244 | 8 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | CEACAM5 PSG1 PSG4 CEACAM6 PGLYRP2 SOCS6 RASSF5 FBXO7 ADAMTS18 LST1 FN1 CBLB PAWR | 1.69e-05 | 264 | 244 | 13 | GO:0050866 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.75e-05 | 28 | 244 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.35e-05 | 15 | 244 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.35e-05 | 15 | 244 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.94e-05 | 31 | 244 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | CEACAM5 PSG1 PSG4 CEACAM6 PGLYRP2 SOCS6 RASSF5 FBXO7 LST1 FN1 CBLB PAWR | 3.07e-05 | 240 | 244 | 12 | GO:0002695 |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.45e-05 | 32 | 244 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 3.45e-05 | 32 | 244 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.03e-05 | 33 | 244 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 4.03e-05 | 17 | 244 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of cell development | GPR137 HDAC9 MYF6 CEACAM5 HDAC4 PSG1 PSG4 RIPK2 CEACAM6 IKZF1 PGLYRP2 CUL7 TTC3 TTBK1 FBXO7 TAL1 PLXNA1 SEMA6C FN1 ADRM1 FZD3 CIT TGM2 DLL3 SMARCA2 SMARCC2 DMRTA2 TNFRSF1A TRIB1 | 4.26e-05 | 1095 | 244 | 29 | GO:0060284 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | CEACAM5 PSG1 PSG4 CEACAM6 PGLYRP2 SOCS6 RASSF5 FBXO7 LST1 CBLB PAWR | 4.51e-05 | 211 | 244 | 11 | GO:0051250 |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.68e-05 | 34 | 244 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | CEACAM5 PSG1 PSG4 CEACAM8 CEACAM6 PTCH1 ESRP2 PLXNA1 LAMA5 TGM2 | 5.35e-05 | 178 | 244 | 10 | GO:0022612 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.40e-05 | 35 | 244 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 7.22e-05 | 86 | 244 | 7 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 7.26e-05 | 149 | 244 | 9 | GO:0062014 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 7.56e-05 | 60 | 244 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 7.56e-05 | 60 | 244 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.11e-05 | 38 | 244 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 9.22e-05 | 39 | 244 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 9.76e-05 | 21 | 244 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 9.76e-05 | 21 | 244 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.03e-04 | 91 | 244 | 7 | GO:0051055 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.04e-04 | 40 | 244 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.16e-04 | 124 | 244 | 8 | GO:0050672 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.18e-04 | 41 | 244 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.29e-04 | 126 | 244 | 8 | GO:0032945 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.32e-04 | 42 | 244 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.41e-04 | 67 | 244 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.42e-04 | 23 | 244 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.69e-04 | 24 | 244 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.69e-04 | 24 | 244 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.69e-04 | 24 | 244 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.85e-04 | 45 | 244 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.94e-04 | 71 | 244 | 6 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.98e-04 | 134 | 244 | 8 | GO:0070664 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.99e-04 | 25 | 244 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.99e-04 | 25 | 244 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.05e-04 | 46 | 244 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.05e-04 | 46 | 244 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.27e-04 | 47 | 244 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.27e-04 | 47 | 244 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.27e-04 | 47 | 244 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | HDAC9 CEACAM5 HDAC4 SPIB PSG1 PSG4 PATZ1 RIPK2 CEACAM6 IKZF1 PGLYRP2 SOCS6 RASSF5 FBXO7 DCAF12 LST1 ADRM1 WASHC1 CBLB NCOR1 PRF1 TIRAP SMARCA2 SMARCC2 PAWR | 2.47e-04 | 976 | 244 | 25 | GO:0046649 |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | CEACAM5 PSG1 PSG4 CEACAM6 CUL7 PTCH1 NKX6-3 NFE2L1 FOXE3 TNFRSF1A | 2.73e-04 | 217 | 244 | 10 | GO:0030856 |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.77e-04 | 49 | 244 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 3.13e-04 | 28 | 244 | 4 | GO:0060445 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DAB2IP HDAC9 ZNF219 HDAC4 IRF2BP1 NOC2L PATZ1 SOX18 IKZF1 PTCH1 PPP1R13L GFI1 ZNF512B ZNF469 NKX6-3 AEBP1 NFE2L1 DLX4 TAL1 CNOT2 NCOR1 SMARCA2 SMARCC2 PAWR PRDM14 CBX8 | 3.26e-04 | 1053 | 244 | 26 | GO:0000122 |
| GeneOntologyBiologicalProcess | cell activation | HDAC9 CEACAM5 HDAC4 SPIB PSG1 PDGFRB PSG4 PATZ1 RIPK2 CEACAM6 IKZF1 PGLYRP2 SOCS6 RASSF5 TTBK1 FBXO7 ADAMTS18 IL17RA DCAF12 LST1 FN1 ADRM1 WASHC1 ADAMTS13 CBLB NCOR1 PRF1 TIRAP SMARCA2 SMARCC2 PAWR | 3.30e-04 | 1356 | 244 | 31 | GO:0001775 |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 3.39e-04 | 145 | 244 | 8 | GO:0045833 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | DAB2IP HDAC9 MYF6 ZNF219 CEACAM5 PSG1 PDGFRB PSG4 BCAS3 CEACAM6 SOX18 PTCH1 DCANP1 PXN STRA6 HERC1 TAL1 CNOT2 PLXNA1 ERVFRD-1 HSPG2 FN1 FZD3 PTPN18 ADAM12 TGM2 CELSR1 DLL3 DCHS1 MMRN2 TNFRSF1A PRDM14 VPS13B | 3.40e-04 | 1483 | 244 | 33 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.60e-04 | 29 | 244 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.67e-04 | 52 | 244 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.02e-04 | 53 | 244 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 4.44e-04 | 151 | 244 | 8 | GO:1902106 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 5.15e-04 | 118 | 244 | 7 | GO:0001570 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 5.17e-04 | 85 | 244 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 5.20e-04 | 56 | 244 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | MYF6 CEACAM5 PSG1 PDGFRB PSG4 CEACAM8 CEACAM6 SOX18 LAMC3 IKZF1 PTCH1 PPP1R13L GFI1 ESRP2 DCANP1 PHOSPHO1 RECQL4 PCDH15 PKP2 STRA6 PLXNA1 FOXE3 HSPG2 COL9A1 FZD3 LAMA5 TGM2 CELSR1 DCHS1 | 5.22e-04 | 1269 | 244 | 29 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.30e-04 | 32 | 244 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle fiber development | 5.40e-04 | 14 | 244 | 3 | GO:0048742 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 6.26e-04 | 159 | 244 | 8 | GO:1903707 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | GPR137 CEACAM5 PSG1 PSG4 RIPK2 CEACAM6 IKZF1 PGLYRP2 FBXO7 TAL1 ADRM1 SMARCA2 SMARCC2 TRIB1 | 6.27e-04 | 429 | 244 | 14 | GO:1902105 |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 6.52e-04 | 160 | 244 | 8 | GO:0038127 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.62e-04 | 59 | 244 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 6.70e-04 | 34 | 244 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | CEACAM5 PSG1 PDGFRB PSG4 RIPK2 CEACAM6 PGLYRP2 SOCS6 RASSF5 TTBK1 FBXO7 ADAMTS18 LST1 FN1 ADRM1 CBLB TIRAP SMARCA2 SMARCC2 PAWR | 7.00e-04 | 756 | 244 | 20 | GO:0050865 |
| GeneOntologyBiologicalProcess | cell fate commitment | MYF6 SOX18 PTCH1 GFI1 EBF2 NKX6-3 NFE2L1 TAL1 DBX1 DLL3 DMRTA2 PRDM14 | 7.36e-04 | 338 | 244 | 12 | GO:0045165 |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 7.71e-04 | 61 | 244 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil differentiation | 8.23e-04 | 4 | 244 | 2 | GO:0045658 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 8.36e-04 | 128 | 244 | 7 | GO:0050795 | |
| GeneOntologyBiologicalProcess | leukocyte activation | HDAC9 CEACAM5 HDAC4 SPIB PSG1 PSG4 PATZ1 RIPK2 CEACAM6 IKZF1 PGLYRP2 SOCS6 RASSF5 TTBK1 FBXO7 DCAF12 LST1 FN1 ADRM1 WASHC1 CBLB NCOR1 PRF1 TIRAP SMARCA2 SMARCC2 PAWR | 8.67e-04 | 1186 | 244 | 27 | GO:0045321 |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 8.75e-04 | 129 | 244 | 7 | GO:0043406 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 8.94e-04 | 63 | 244 | 5 | GO:0021515 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 8.94e-04 | 63 | 244 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 9.84e-04 | 17 | 244 | 3 | GO:0007638 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical NF-kappaB signal transduction | 1.02e-03 | 213 | 244 | 9 | GO:0043123 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.03e-03 | 38 | 244 | 4 | GO:0007435 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | GPR137 CEACAM5 PSG1 PSG4 CEACAM6 PGLYRP2 TTC3 FBXO7 SEMA6C CIT DLL3 TRIB1 | 1.07e-03 | 353 | 244 | 12 | GO:0010721 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 1.09e-03 | 134 | 244 | 7 | GO:0019217 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.10e-03 | 66 | 244 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DAB2IP HDAC9 MYF6 ZNF219 HDAC4 IRF2BP1 NOC2L PATZ1 SOX18 IKZF1 PTCH1 PPP1R13L MIDEAS GFI1 ZNF512B ZNF469 NKX6-3 AEBP1 NFE2L1 DLX4 TAL1 CNOT2 PARP10 NCOR1 SMARCA2 SMARCC2 PAWR PRDM14 CBX8 HR | 1.16e-03 | 1399 | 244 | 30 | GO:0045892 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 8.35e-07 | 16 | 245 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | basement membrane | 9.69e-05 | 122 | 245 | 8 | GO:0005604 | |
| MousePheno | decreased fatty acid oxidation | 1.03e-06 | 24 | 206 | 6 | MP:0014172 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.11e-05 | 21 | 206 | 5 | MP:0031415 | |
| MousePheno | abnormal cellular glucose uptake | 1.93e-05 | 102 | 206 | 9 | MP:0003925 | |
| MousePheno | decreased muscle cell glucose uptake | 2.07e-05 | 39 | 206 | 6 | MP:0030022 | |
| MousePheno | increased abdominal fat pad weight | 4.10e-05 | 27 | 206 | 5 | MP:0009286 | |
| MousePheno | increased insulin secretion | 4.16e-05 | 64 | 206 | 7 | MP:0003058 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 8.23e-05 | 31 | 206 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 8.23e-05 | 31 | 206 | 5 | MP:0008964 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 9.38e-05 | 17 | 206 | 4 | MP:0031047 | |
| MousePheno | decreased cellular glucose uptake | 1.23e-04 | 53 | 206 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 1.36e-04 | 54 | 206 | 6 | MP:0010953 | |
| MousePheno | abnormal abdominal fat pad morphology | CEACAM5 KMT2B PSG1 PSG4 CEACAM8 CEACAM6 AQP7P3 DOK1 ADRM1 AQP7 NCOR1 ATP6AP2 TRIB1 | 1.38e-04 | 262 | 206 | 13 | MP:0000010 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.50e-04 | 35 | 206 | 5 | MP:0031618 | |
| MousePheno | hairless | 1.67e-04 | 8 | 206 | 3 | MP:0003815 | |
| MousePheno | abnormal muscle triglyceride level | 1.72e-04 | 36 | 206 | 5 | MP:0031412 | |
| MousePheno | curly tail | 1.85e-04 | 57 | 206 | 6 | MP:0003051 | |
| MousePheno | decreased urine glycerol level | 2.16e-04 | 2 | 206 | 2 | MP:0030781 | |
| MousePheno | decreased respiratory quotient | 2.20e-04 | 110 | 206 | 8 | MP:0010379 | |
| MousePheno | increased incidence of induced tumors | CEACAM5 PSG1 PSG4 CEACAM6 CUL9 PTCH1 ADAMTS18 POLH PTPRT PRF1 | 2.45e-04 | 173 | 206 | 10 | MP:0002021 |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | CEACAM5 PSG1 PSG4 CEACAM6 PGLYRP2 FBXO7 PLEKHA7 TAP1 LST1 PRF1 OASL LTB TNFRSF1A | 2.57e-04 | 279 | 206 | 13 | MP:0009785 |
| MousePheno | impaired glucose tolerance | PALD1 CEACAM5 KMT2B PSG1 PSG4 CEACAM8 CEACAM6 EBF2 PTPRN2 SIK2 HERC1 TRAPPC9 GPBAR1 FZD3 TGM2 PRDM14 TRIB1 VPS13B | 2.69e-04 | 480 | 206 | 18 | MP:0005293 |
| MousePheno | abnormal lipid oxidation | 2.69e-04 | 61 | 206 | 6 | MP:0010951 | |
| MousePheno | increased tumor incidence | CEACAM5 PSG1 PSG4 CEACAM6 CUL9 IKZF1 PTCH1 RASSF5 RECQL4 ADAMTS18 PCBP4 TRAPPC9 DOK1 POLH PTPRT LZTS1 PRF1 TNFRSF1A HR | 3.20e-04 | 530 | 206 | 19 | MP:0002020 |
| Domain | Cadherin_CS | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 1.66e-06 | 109 | 244 | 10 | IPR020894 |
| Domain | Cul7 | 2.20e-06 | 3 | 244 | 3 | PF11515 | |
| Domain | CPH_domain | 2.20e-06 | 3 | 244 | 3 | IPR021097 | |
| Domain | CADHERIN_1 | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.30e-06 | 113 | 244 | 10 | PS00232 |
| Domain | Cadherin | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.30e-06 | 113 | 244 | 10 | PF00028 |
| Domain | CADHERIN_2 | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.50e-06 | 114 | 244 | 10 | PS50268 |
| Domain | - | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.50e-06 | 114 | 244 | 10 | 2.60.40.60 |
| Domain | CA | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.70e-06 | 115 | 244 | 10 | SM00112 |
| Domain | Cadherin-like | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 2.92e-06 | 116 | 244 | 10 | IPR015919 |
| Domain | Cadherin | PCDH17 PCDH15 PCDHGC4 PCDHGB6 PCDHAC2 PCDHA5 CELSR1 PCDHGB4 DCHS1 CDH8 | 3.42e-06 | 118 | 244 | 10 | IPR002126 |
| Domain | Ig_2 | 4.89e-06 | 73 | 244 | 8 | PF13895 | |
| Domain | - | CEACAM5 PSG1 PDGFRB PSG4 PSG7 SPEG INSRR CEACAM8 CEACAM6 IL22RA1 EBF2 CILP2 PLXNA1 EBF4 SECTM1 HSPG2 COL7A1 FN1 PTPRT TGM2 RIMBP2 IGSF9B IGSF21 | 2.11e-05 | 663 | 244 | 23 | 2.60.40.10 |
| Domain | Ig-like_fold | CEACAM5 PSG1 PDGFRB PSG4 PSG7 SPEG INSRR CEACAM8 CEACAM6 IL22RA1 EBF2 CILP2 PLXNA1 EBF4 SECTM1 HSPG2 COL7A1 FN1 PTPRT TGM2 RIMBP2 IGSF9B IGSF21 | 5.58e-05 | 706 | 244 | 23 | IPR013783 |
| Domain | APC_su10/DOC_dom | 7.42e-05 | 7 | 244 | 3 | IPR004939 | |
| Domain | DOC | 7.42e-05 | 7 | 244 | 3 | PS51284 | |
| Domain | ANAPC10 | 7.42e-05 | 7 | 244 | 3 | PF03256 | |
| Domain | APC10 | 7.42e-05 | 7 | 244 | 3 | SM01337 | |
| Domain | Cadherin_tail | 1.13e-04 | 37 | 244 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.13e-04 | 37 | 244 | 5 | IPR031904 | |
| Domain | LAMININ_IVA | 1.18e-04 | 8 | 244 | 3 | PS51115 | |
| Domain | Laminin_B | 1.18e-04 | 8 | 244 | 3 | PF00052 | |
| Domain | LamB | 1.18e-04 | 8 | 244 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.18e-04 | 8 | 244 | 3 | IPR000034 | |
| Domain | PTPc_motif | 1.18e-04 | 59 | 244 | 6 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.18e-04 | 59 | 244 | 6 | IPR003595 | |
| Domain | MYB_LIKE | 1.29e-04 | 38 | 244 | 5 | PS50090 | |
| Domain | PTPase_domain | 1.86e-04 | 41 | 244 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 1.86e-04 | 41 | 244 | 5 | PF00102 | |
| Domain | Cadherin_2 | 2.03e-04 | 65 | 244 | 6 | PF08266 | |
| Domain | Cadherin_N | 2.03e-04 | 65 | 244 | 6 | IPR013164 | |
| Domain | IGc2 | CEACAM5 PSG1 PDGFRB PSG4 PSG7 SPEG CEACAM8 CEACAM6 CILP2 HSPG2 IGSF9B | 2.77e-04 | 235 | 244 | 11 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 PSG1 PDGFRB PSG4 PSG7 SPEG CEACAM8 CEACAM6 CILP2 HSPG2 IGSF9B | 2.77e-04 | 235 | 244 | 11 | IPR003598 |
| Domain | SANT | 4.79e-04 | 50 | 244 | 5 | SM00717 | |
| Domain | HDAC4_Gln | 5.06e-04 | 3 | 244 | 2 | PF12203 | |
| Domain | Hist_deacetylase_Gln_rich_N | 5.06e-04 | 3 | 244 | 2 | IPR024643 | |
| Domain | SANT/Myb | 5.75e-04 | 52 | 244 | 5 | IPR001005 | |
| Domain | EGF_LAM_2 | 5.96e-04 | 30 | 244 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 5.96e-04 | 30 | 244 | 4 | PS01248 | |
| Domain | V-set | 7.21e-04 | 184 | 244 | 9 | PF07686 | |
| Domain | ig | 9.06e-04 | 190 | 244 | 9 | PF00047 | |
| Domain | Immunoglobulin | 9.06e-04 | 190 | 244 | 9 | IPR013151 | |
| Domain | HSA | 1.00e-03 | 4 | 244 | 2 | SM00573 | |
| Domain | HSA | 1.00e-03 | 4 | 244 | 2 | PS51204 | |
| Domain | COE | 1.00e-03 | 4 | 244 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 1.00e-03 | 4 | 244 | 2 | IPR003523 | |
| Domain | COE_HLH | 1.00e-03 | 4 | 244 | 2 | IPR032201 | |
| Domain | COE_DBD | 1.00e-03 | 4 | 244 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 1.00e-03 | 4 | 244 | 2 | IPR018350 | |
| Domain | COE1_HLH | 1.00e-03 | 4 | 244 | 2 | PF16423 | |
| Domain | COE1_DBD | 1.00e-03 | 4 | 244 | 2 | PF16422 | |
| Domain | Histone_deAcase_II_euk | 1.00e-03 | 4 | 244 | 2 | IPR017320 | |
| Domain | HSA_dom | 1.00e-03 | 4 | 244 | 2 | IPR014012 | |
| Domain | HSA | 1.00e-03 | 4 | 244 | 2 | PF07529 | |
| Domain | EGF_Lam | 1.08e-03 | 35 | 244 | 4 | SM00180 | |
| Domain | Laminin_EGF | 1.08e-03 | 35 | 244 | 4 | PF00053 | |
| Domain | Myb_DNA-binding | 1.08e-03 | 35 | 244 | 4 | PF00249 | |
| Domain | PTPc | 1.21e-03 | 36 | 244 | 4 | SM00194 | |
| Domain | Ig_V-set | 1.25e-03 | 199 | 244 | 9 | IPR013106 | |
| Domain | - | 1.31e-03 | 92 | 244 | 6 | 3.90.190.10 | |
| Domain | Galactose-bd-like | 1.46e-03 | 94 | 244 | 6 | IPR008979 | |
| Domain | Laminin_EGF | 1.48e-03 | 38 | 244 | 4 | IPR002049 | |
| Domain | Rib_L2_dom2 | 1.55e-03 | 18 | 244 | 3 | IPR014722 | |
| Domain | - | 1.55e-03 | 18 | 244 | 3 | 2.30.30.30 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.63e-03 | 39 | 244 | 4 | PS50055 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.90e-03 | 99 | 244 | 6 | IPR029021 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.26e-05 | 30 | 164 | 5 | M27216 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 3.01e-05 | 6 | 164 | 3 | M26970 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 DAB2IP PALD1 KMT2B BCAS3 SPEG CUL9 LAMC3 ZNF395 PTCH1 TTC3 PLEKHH3 ESRP2 ZCCHC14 ZMIZ2 PXN DTX2 HERC2 HERC1 C1orf50 PLXNA1 TRAPPC9 PRRC2B SEMA6C DPH2 HSPG2 EP400 ESYT1 LAMA5 FAAP100 CIT MADD NCOR1 RADIL CELSR1 ARHGEF40 SNAPC4 TRIB1 PRRT4 ARHGAP33 HR | 6.20e-18 | 1105 | 250 | 41 | 35748872 |
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 28567513 | ||
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 8207827 | ||
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 11994468 | ||
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 20381490 | ||
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 22159884 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 3.50e-08 | 14 | 250 | 5 | 27161904 | |
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 23070997 | ||
| Pubmed | 3.50e-08 | 14 | 250 | 5 | 10491101 | ||
| Pubmed | 5.22e-08 | 15 | 250 | 5 | 24948196 | ||
| Pubmed | 5.22e-08 | 15 | 250 | 5 | 20410265 | ||
| Pubmed | 5.22e-08 | 15 | 250 | 5 | 26586918 | ||
| Pubmed | KMT2B IRF2BP1 PPP1R13L TTC3 ZNF512B PKP2 NID1 HERC2 HERC1 HSPG2 USP13 FN1 RANBP9 IKBKG LAMA5 CBLB RGS3 NCOR1 TGM2 | 6.98e-08 | 591 | 250 | 19 | 15231748 | |
| Pubmed | 7.55e-08 | 16 | 250 | 5 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 7.55e-08 | 16 | 250 | 5 | 11284729 | |
| Pubmed | alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. | 8.97e-08 | 7 | 250 | 4 | 9151677 | |
| Pubmed | 1.06e-07 | 17 | 250 | 5 | 23734002 | ||
| Pubmed | 3.58e-07 | 63 | 250 | 7 | 11572484 | ||
| Pubmed | AMER1 MBNL1 RIPK2 ZCCHC14 DTX2 HERC2 HERC1 C1orf50 MTUS2 USP13 IKBKG PTPN23 TAB3 MADD PARP10 WDR6 MRPS2 P3H2 | 4.70e-07 | 604 | 250 | 18 | 38803224 | |
| Pubmed | WBP11 KMT2B NOC2L GFI1 PCDH17 RASSF5 PTPRN2 DTX2 PCBP4 PRRC2B HSPG2 PLEKHG4 ADRM1 NUDT21 NCOR1 RADIL NSMF SMARCC2 | 5.17e-07 | 608 | 250 | 18 | 16713569 | |
| Pubmed | WBP11 KMT2B IRF2BP1 MBNL1 CUL9 CUL7 MIDEAS ZNF512B ZMIZ2 HERC2 HERC1 TAL1 CNOT2 TRAPPC9 PRRC2B HSPG2 EP400 ADRM1 POLH IKBKG CIT TAB3 KIAA1671 NCOR1 LIG3 MRPS2 SMARCA2 SMARCC2 TRIB1 | 5.47e-07 | 1429 | 250 | 29 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | HDAC4 LMTK3 PTCH1 ZNF469 AEBP1 NFE2L1 ZMIZ2 PLEKHA7 MEX3B MGRN1 EP400 KIAA1671 ARHGAP6 NCOR1 IGSF9B | 6.27e-07 | 430 | 250 | 15 | 35044719 |
| Pubmed | DAB2IP WBP11 CUL7 PPP1R13L ZNF512B PTPRN2 CASKIN2 PXN HERC2 HERC1 PLEKHA7 PRRC2B ELOA SCYL3 KIAA1549 PTPN23 PTPN18 CDC14A PTPRT TAB3 MADD KIAA1671 NCOR1 CBX8 | 7.05e-07 | 1049 | 250 | 24 | 27880917 | |
| Pubmed | 1.43e-06 | 77 | 250 | 7 | 10835267 | ||
| Pubmed | 1.46e-06 | 4 | 250 | 3 | 26483485 | ||
| Pubmed | DAB2IP PALD1 SPEG CUL9 STRIP2 RUSC2 KLHL29 ZCCHC14 PRRC2B EP400 FRMPD1 MADD RIMBP2 VPS13B | 1.76e-06 | 407 | 250 | 14 | 12693553 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.77e-06 | 13 | 250 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.77e-06 | 13 | 250 | 4 | 19273835 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 20044046 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 32150576 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.77e-06 | 13 | 250 | 4 | 12832451 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 25406283 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 8380065 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 1279194 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 25724769 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.77e-06 | 13 | 250 | 4 | 22092845 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.77e-06 | 13 | 250 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.77e-06 | 13 | 250 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.77e-06 | 13 | 250 | 4 | 23800882 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.77e-06 | 13 | 250 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.77e-06 | 13 | 250 | 4 | 39168268 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 8402684 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.77e-06 | 13 | 250 | 4 | 21949477 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 26219866 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 2133556 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.77e-06 | 13 | 250 | 4 | 19358828 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.77e-06 | 13 | 250 | 4 | 34058224 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.77e-06 | 13 | 250 | 4 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.77e-06 | 13 | 250 | 4 | 25972571 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.77e-06 | 13 | 250 | 4 | 15220458 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 18843289 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 15207636 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 21081647 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 11133662 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 11483763 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 18003729 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.77e-06 | 13 | 250 | 4 | 27695943 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.77e-06 | 13 | 250 | 4 | 16638824 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.77e-06 | 13 | 250 | 4 | 21670291 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 22162753 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 2702644 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 11801635 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 21760897 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 1719235 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 16619040 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.77e-06 | 13 | 250 | 4 | 8209741 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 32521208 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.77e-06 | 13 | 250 | 4 | 29967450 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 1653760 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 32169849 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.77e-06 | 13 | 250 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.77e-06 | 13 | 250 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.77e-06 | 13 | 250 | 4 | 15316023 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 15331748 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.77e-06 | 13 | 250 | 4 | 22406619 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 7628460 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 19008452 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 2164599 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 29396368 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.77e-06 | 13 | 250 | 4 | 33352461 | |
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 38381498 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 1633107 | ||
| Pubmed | 1.77e-06 | 13 | 250 | 4 | 26911181 | ||
| Interaction | TOP3B interactions | VWA5B2 DAB2IP PALD1 KMT2B HDAC4 NOC2L BCAS3 SPEG CUL9 LAMC3 ZNF395 PTCH1 TTC3 PLEKHH3 ESRP2 ZCCHC14 ZMIZ2 PXN PKP2 DTX2 HERC2 HERC1 C1orf50 MEX3B CNOT2 PLXNA1 TRAPPC9 PRRC2B SEMA6C DPH2 HSPG2 EP400 NUDT21 ESYT1 LAMA5 FAAP100 CIT CDC14A MADD NCOR1 LIG3 RADIL CELSR1 ARHGEF40 ATP6AP2 SNAPC4 TRIB1 PRRT4 ARHGAP33 HR | 2.70e-11 | 1470 | 246 | 50 | int:TOP3B |
| Interaction | D2HGDH interactions | VWA5B2 CUL7 PPP1R13L PLEKHH3 ESRP2 HERC1 PLEKHG4 IKBKG MADD KIAA1671 SMG8 VPS13B | 2.43e-07 | 146 | 246 | 12 | int:D2HGDH |
| Interaction | BAG2 interactions | VWA5B2 PALD1 HDAC4 IRF2BP1 MBNL1 CUL7 PPP1R13L ESRP2 RECQL4 FBXO7 SIK2 PXN TACC3 DPH2 FN1 ESYT1 PTPN23 PTPN18 CIT KIAA1671 NCOR1 SMG8 ARHGEF10 VPS13B | 7.19e-07 | 622 | 246 | 24 | int:BAG2 |
| Interaction | SIRPD interactions | 1.03e-05 | 86 | 246 | 8 | int:SIRPD | |
| Interaction | RFXANK interactions | HDAC9 HDAC4 IRF2BP1 PLEKHH3 ESRP2 HOXC12 RECQL4 FBXO7 SMG8 ARHGEF10 | 1.27e-05 | 146 | 246 | 10 | int:RFXANK |
| Interaction | ZNF252P-AS1 interactions | 1.69e-05 | 27 | 246 | 5 | int:ZNF252P-AS1 | |
| Interaction | SP7 interactions | WBP11 KMT2B IRF2BP1 MBNL1 MIDEAS ZMIZ2 DLX4 PRRC2B EP400 POLH CBLB NCOR1 SMARCA2 SMARCC2 | 2.39e-05 | 304 | 246 | 14 | int:SP7 |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 PDGFRB CEACAM8 CEACAM6 CILP2 HSPG2 PTPRT IGSF9B IGSF21 | 1.12e-04 | 193 | 175 | 9 | 594 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.39e-04 | 11 | 175 | 3 | 1315 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.58e-04 | 53 | 175 | 5 | 532 | |
| GeneFamily | Clustered protocadherins | 3.86e-04 | 64 | 175 | 5 | 20 | |
| GeneFamily | Histone deacetylases, class IIA | 5.52e-04 | 4 | 175 | 2 | 992 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.06e-03 | 163 | 175 | 7 | 590 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.55e-03 | 24 | 175 | 3 | 906 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.94e-03 | 181 | 175 | 7 | 694 | |
| GeneFamily | Cullins | 2.51e-03 | 8 | 175 | 2 | 1032 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | MYF6 NOC2L INSRR HPSE2 CSMD2 ADCY8 PCDH17 RASSF5 HOXC12 FOXD4L1 PTPRN2 SCNN1G ADAMTS18 ASCL4 DLX4 TAL1 TAP1 FOXE3 SECTM1 CACNA1B ADCY4 PCDHGC4 FRMPD1 TMEM255B PTPRT TMEM132E IGSF21 CBX8 HR | 1.06e-06 | 1115 | 250 | 29 | M10371 |
| Coexpression | BENPORATH_SUZ12_TARGETS | MYF6 INSRR HPSE2 GFI1 ADCY8 PCDH17 RASSF5 CTPS2 HOXC12 FOXD4L1 SCNN1G ADAMTS18 ASCL4 DLX4 IL17RA TAL1 FOXE3 SECTM1 CACNA1B ADCY4 FRMPD1 ADAM12 PTPRT ARHGAP6 TMEM132E IGSF21 CBX8 | 2.42e-06 | 1035 | 250 | 27 | M9898 |
| Coexpression | LIU_PROSTATE_CANCER_DN | DAB2IP CYP3A5 SPEG CEACAM6 ZNF395 TMEM200B KLHL29 ZCCHC14 MYO15B AEBP1 MRC2 NID1 HSPG2 COL7A1 ADCY4 COL9A1 ARHGEF40 | 5.91e-06 | 493 | 250 | 17 | M19391 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | GPR137 BCAS3 CUL9 ADCY8 MYO15B CASKIN2 RECQL4 STRA6 PRRC2B FN1 RANBP9 CBLB PTPN18 MADD ATP6AP2 OASL SMARCA2 TNFRSF1A | 9.70e-06 | 567 | 250 | 18 | M16909 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.95e-05 | 35 | 250 | 5 | MM757 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.47e-05 | 20 | 250 | 4 | MM17053 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SOX18 LAMC3 IKZF1 SLC16A12 PCDH17 STRIP2 EBF2 ESRP2 SCNN1G ADAMTS18 PKP2 IL17RA FAM181B TAP1 EBF4 DOK1 TICRR FN1 PTPN18 CDC14A ELFN1 DLL3 DMRTA2 PAWR IGSF21 | 3.92e-05 | 1074 | 250 | 25 | M1941 |
| Coexpression | BENPORATH_PRC2_TARGETS | MYF6 INSRR HPSE2 ADCY8 PCDH17 RASSF5 HOXC12 FOXD4L1 SCNN1G ADAMTS18 DLX4 TAL1 CACNA1B ADCY4 PTPRT TMEM132E IGSF21 CBX8 | 5.82e-05 | 650 | 250 | 18 | M8448 |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 LAMC3 CILP2 AEBP1 NID1 HSPG2 COL7A1 COL9A1 FN1 LAMA5 MMRN2 | 6.19e-05 | 270 | 250 | 11 | MM17057 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 6.20e-05 | 23 | 250 | 4 | M48001 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | ZNF219 HDAC4 MBNL1 RUSC2 KLHL29 AEBP1 PXN PCBP4 HSPG2 COL7A1 CBLB TMEM255B PTPRT P3H2 DCHS1 | 6.30e-05 | 479 | 250 | 15 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | ZNF219 HDAC4 MBNL1 RUSC2 KLHL29 AEBP1 PXN PCBP4 HSPG2 COL7A1 CBLB TMEM255B PTPRT P3H2 DCHS1 | 6.91e-05 | 483 | 250 | 15 | MM1082 |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 LAMC3 CILP2 AEBP1 NID1 HSPG2 COL7A1 COL9A1 FN1 LAMA5 MMRN2 | 7.29e-05 | 275 | 250 | 11 | M5884 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 8.12e-05 | 108 | 250 | 7 | MM1334 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 8.24e-05 | 75 | 250 | 6 | MM605 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 1.18e-04 | 196 | 250 | 9 | M8503 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | SOX18 IKZF1 GFI1 SCNN1G FOXE3 PTPRT CELSR1 TMEM132E DBX1 IGSF21 CDH8 HR | 1.30e-04 | 345 | 250 | 12 | M2009 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | IKZF1 COQ2 RASSF5 PRRC2B PTPN18 NCOR1 SMARCA2 TNFRSF1A SNAPC4 | 1.32e-04 | 199 | 250 | 9 | M9443 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP | 1.32e-04 | 199 | 250 | 9 | M7474 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP | INSRR TTC3 PLEKHH3 MYO15B LAMA5 ATP6AP2 IGSF21 PRDM14 ARHGAP33 | 1.37e-04 | 200 | 250 | 9 | M9289 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | SOX18 IKZF1 GFI1 SCNN1G FOXE3 PTPRT CELSR1 TMEM132E DBX1 IGSF21 CDH8 HR | 1.37e-04 | 347 | 250 | 12 | MM860 |
| Coexpression | NABA_MATRISOME | VWA5B2 HPSE2 LAMC3 CILP2 AEBP1 TCHHL1 ADAMTS18 NID1 ITIH6 PLXNA1 SEMA6C HSPG2 COL7A1 COL9A1 FN1 LAMA5 ADAMTS13 ADAM12 TGM2 ELFN1 P3H2 MMRN2 LTB | 1.41e-04 | 1026 | 250 | 23 | M5889 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.42e-04 | 201 | 250 | 9 | MM1294 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.50e-04 | 159 | 250 | 8 | MM760 | |
| Coexpression | XIE_LT_HSC_S1PR3_OE_UP | 1.59e-04 | 29 | 250 | 4 | M41754 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | HDAC9 PALD1 CEACAM5 SPIB MRC2 TAP1 MTUS2 TMEM132E P3H2 LTB IGSF21 HR | 5.86e-10 | 183 | 250 | 12 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 LAMA5 TMEM255B TGM2 ELFN1 DCHS1 MMRN2 TNFRSF1A | 1.53e-09 | 199 | 250 | 12 | f5c8ad751d21ea0b199a02846faecd04bf100033 |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SOX18 PCDH17 CASKIN2 FAM181B ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.20e-08 | 191 | 250 | 11 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SOX18 PCDH17 CASKIN2 FAM181B ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.20e-08 | 191 | 250 | 11 | a0018f88f7132477cc467ee15db029a585290595 |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SOX18 PCDH17 CASKIN2 FAM181B ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.20e-08 | 191 | 250 | 11 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 CASKIN2 TAL1 ADCY4 LAMA5 TMEM255B AQP7 KIAA1671 TGM2 MMRN2 | 1.56e-08 | 196 | 250 | 11 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 CASKIN2 TAL1 ADCY4 LAMA5 TMEM255B AQP7 KIAA1671 TGM2 MMRN2 | 1.56e-08 | 196 | 250 | 11 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 CASKIN2 TAL1 ADCY4 LAMA5 TMEM255B AQP7 KIAA1671 TGM2 MMRN2 | 1.56e-08 | 196 | 250 | 11 | 039044ab28c53391c34d8226fb8cf78549e63ef4 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PDGFRB LAMC3 EBF2 AEBP1 MRC2 NID1 STRA6 PLXNA1 HSPG2 COL7A1 FN1 | 1.74e-08 | 198 | 250 | 11 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PDGFRB LAMC3 EBF2 AEBP1 MRC2 NID1 STRA6 PLXNA1 HSPG2 COL7A1 FN1 | 1.74e-08 | 198 | 250 | 11 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SOX18 PCDH17 CASKIN2 TAL1 HSPG2 ADCY4 FN1 TMEM255B TGM2 DCHS1 MMRN2 | 1.83e-08 | 199 | 250 | 11 | da5a88749d859d535daa030d0974485906cc0ba7 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | VWA5B2 DAB2IP SOX18 NID1 HSPG2 ADCY4 TMEM255B ELFN1 SMARCA2 MMRN2 | 1.06e-07 | 186 | 250 | 10 | a906020a8df6fcca474b278f746c553b177a56b4 |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DAB2IP SOX18 PCDH17 FAM181B ADCY4 LAMA5 AQP7 KIAA1671 TGM2 MMRN2 | 1.18e-07 | 188 | 250 | 10 | e901a9bdf00b8e91806f445af66647373bf62661 |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 FAM181B TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.50e-07 | 193 | 250 | 10 | 724bb613fa434add5b1c5586b629328f819fbdfe |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 PRRT4 | 1.50e-07 | 193 | 250 | 10 | e164f6403a8b541ced08a6feec915d2e855036ea |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 FAM181B TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.50e-07 | 193 | 250 | 10 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 FAM181B TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 | 1.50e-07 | 193 | 250 | 10 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 PRRT4 | 1.50e-07 | 193 | 250 | 10 | b32533afeff1905e188becaa09079e9699722e4b |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX18 PCDH17 TAL1 ADCY4 LAMA5 TMEM255B AQP7 TGM2 MMRN2 PRRT4 | 1.50e-07 | 193 | 250 | 10 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | HDAC9 SOX18 PCDH17 HSPG2 ADCY4 KIAA1671 TGM2 MMRN2 IGSF9B CDH8 | 1.58e-07 | 194 | 250 | 10 | efd5efed060edb7f24d59600981bb60ec28ac2ef |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PDGFRB LAMC3 SLC16A12 NID1 STRA6 ADCY4 FN1 ADAM12 LZTS1 MMRN2 | 1.73e-07 | 196 | 250 | 10 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 LAMA5 TMEM255B TGM2 ELFN1 MMRN2 | 1.82e-07 | 197 | 250 | 10 | 951f18f326967206adbbfc422cce9eea3d2e0854 |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | HDAC9 SOX18 PCDH17 TAL1 HSPG2 ADCY4 TMEM255B KIAA1671 MMRN2 CDH8 | 1.82e-07 | 197 | 250 | 10 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | SOX18 PCDH17 ADAMTS18 NID1 HSPG2 ADCY4 FN1 TMEM255B DCHS1 MMRN2 | 1.82e-07 | 197 | 250 | 10 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-07 | 197 | 250 | 10 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 LAMA5 TMEM255B TGM2 ELFN1 MMRN2 | 1.82e-07 | 197 | 250 | 10 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 TMEM255B TGM2 ELFN1 DCHS1 MMRN2 | 1.90e-07 | 198 | 250 | 10 | f83956c4b13b5d0a0c6e3d9f580dbf99649ef175 |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | HDAC9 SOX18 PCDH17 PHOSPHO1 ADCY4 TMEM255B TGM2 ELFN1 MMRN2 IGSF9B | 1.90e-07 | 198 | 250 | 10 | 6fd984da5d2c419aeb34c8cbd8a00440e2f820a5 |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 TMEM255B TGM2 ELFN1 DCHS1 MMRN2 | 1.90e-07 | 198 | 250 | 10 | 5b5ccce5de82ea041465e656147cec3b8beb865b |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 FN1 TMEM255B TGM2 DCHS1 MMRN2 | 2.00e-07 | 199 | 250 | 10 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SOX18 CASKIN2 TAL1 HSPG2 ADCY4 FN1 TMEM255B DCHS1 MMRN2 TNFRSF1A | 2.00e-07 | 199 | 250 | 10 | e6715288a586631676722f2323f0d833431161cf |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 FN1 TMEM255B TGM2 DCHS1 MMRN2 | 2.09e-07 | 200 | 250 | 10 | 2e47888e041ec3d265425d1df97b6665c6da889c |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 FN1 TMEM255B TGM2 DCHS1 MMRN2 | 2.09e-07 | 200 | 250 | 10 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.01e-07 | 159 | 250 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IQANK1 GPR162 DLX4 SEMA6C DNAH3 C11orf16 CDC14A PTPRT CELSR1 | 5.56e-07 | 171 | 250 | 9 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-07 | 171 | 250 | 9 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-07 | 171 | 250 | 9 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-07 | 175 | 250 | 9 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-07 | 175 | 250 | 9 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.55e-07 | 180 | 250 | 9 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.55e-07 | 180 | 250 | 9 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-07 | 183 | 250 | 9 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-07 | 183 | 250 | 9 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-07 | 183 | 250 | 9 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 185 | 250 | 9 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.12e-06 | 186 | 250 | 9 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 186 | 250 | 9 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-06 | 187 | 250 | 9 | 29b2e2be26a9d72b154760e47acf61cfe2f45fa7 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-06 | 187 | 250 | 9 | 106f50ad85a92403037214f0e94702230284837f | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 188 | 250 | 9 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 188 | 250 | 9 | 5d166d9e71632edd059ff0a9f66f8763f259d40a | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 188 | 250 | 9 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 188 | 250 | 9 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 188 | 250 | 9 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-06 | 188 | 250 | 9 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.28e-06 | 189 | 250 | 9 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 190 | 250 | 9 | 9aaa48f3aad813c87a45efdbb67d255c94f6e6a4 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.34e-06 | 190 | 250 | 9 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.34e-06 | 190 | 250 | 9 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 190 | 250 | 9 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 190 | 250 | 9 | 14cdb660ad3aabcf49572173e7628d8b99dcbe6f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-06 | 190 | 250 | 9 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 191 | 250 | 9 | 54029b68fb78163c969890886ab0f8fb0dcf3c20 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-06 | 191 | 250 | 9 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | EC|World / Lineage and Cell class | 1.46e-06 | 192 | 250 | 9 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-06 | 193 | 250 | 9 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.53e-06 | 193 | 250 | 9 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-06 | 193 | 250 | 9 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PALD1 PCDH17 CASKIN2 ADAMTS18 HSPG2 ADCY4 FN1 TMEM255B MMRN2 | 1.53e-06 | 193 | 250 | 9 | 1f978e102a029a6beb10913052cd0a20c7253e8e |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 193 | 250 | 9 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 193 | 250 | 9 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 250 | 9 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | facs-Thymus-Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 250 | 9 | 255d6eead8da740a942a5e7d554dbd895d736d1a | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SOX18 PCDH17 CASKIN2 TAL1 ADCY4 TMEM255B KIAA1671 MMRN2 CDH8 | 1.59e-06 | 194 | 250 | 9 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-06 | 194 | 250 | 9 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | SOX18 PCDH17 CASKIN2 HSPG2 ADCY4 TMEM255B KIAA1671 TGM2 MMRN2 | 1.66e-06 | 195 | 250 | 9 | dfc5da514fb34a2c318a5c4c61f44049fa43960e |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SOX18 PCDH17 CASKIN2 TAL1 ADCY4 TMEM255B KIAA1671 MMRN2 CDH8 | 1.73e-06 | 196 | 250 | 9 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 196 | 250 | 9 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.73e-06 | 196 | 250 | 9 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-06 | 196 | 250 | 9 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 196 | 250 | 9 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | PALD1 SOX18 PCDH17 CASKIN2 TAL1 ADCY4 ZDHHC14 TMEM255B KIAA1671 | 1.73e-06 | 196 | 250 | 9 | 96c6d78482a130ce4e29f6629972a06d10d7530e |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 198 | 250 | 9 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-06 | 198 | 250 | 9 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-06 | 198 | 250 | 9 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 368C-Endothelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 198 | 250 | 9 | 9a2c2201baee51581733e183065298a97eba4553 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-06 | 198 | 250 | 9 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-06 | 198 | 250 | 9 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.88e-06 | 198 | 250 | 9 | 56b746e5791b47fe33a7872f0942ae0747b13d4a | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-06 | 198 | 250 | 9 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.96e-06 | 148 | 250 | 8 | a261c6d3d9cf0311c053fca66c37d39e66db6ad8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like-IPs_and_early_cortical_neurons|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.96e-06 | 148 | 250 | 8 | c0237ba7d4040b6a497094b362dfb8b3a97a7d06 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.96e-06 | 199 | 250 | 9 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 199 | 250 | 9 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| Computational | Heart genes. | SPIB PDGFRB PSG7 DLEC1 PCBP4 TAP1 LST1 DOK1 HSPG2 FN1 AQP7 RGS3 TGM2 PRF1 LTB TRIB1 | 7.12e-05 | 423 | 134 | 16 | MODULE_60 |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | BCAS3 CUL9 RUSC2 PXN TACC3 HERC1 EP400 NCOR1 CELSR1 NSMF SMARCA2 TMC5 | 1.89e-06 | 196 | 250 | 12 | 2056_DN |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A | ZNF219 CUL9 ZNF512B PRKD3 SIK2 PCBP4 ABHD14A CDC14A EDEM3 LIG3 WDR6 SNAPC4 | 1.89e-06 | 196 | 250 | 12 | 1678_DN |
| Drug | AC1L1IPV | 7.16e-06 | 43 | 250 | 6 | CID000004683 | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | CEACAM6 PTPRN2 NID1 IL17RA HSPG2 FN1 PTPN18 FAAP100 ARHGAP6 ARHGEF10 OASL | 1.06e-05 | 194 | 250 | 11 | 7247_UP |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A | IRF2BP1 RUSC2 ZMIZ2 CLN6 PLXNA1 DNAH3 POLH ADAM12 FAAP100 CDC14A SNAPC4 | 1.11e-05 | 195 | 250 | 11 | 1827_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HT_HG-U133A | ZNF219 CEACAM6 PTCH1 ZMIZ2 TAL1 PLXNA1 FRMPD1 PCDHA5 PTPN18 SMARCA2 MMRN2 | 1.16e-05 | 196 | 250 | 11 | 6313_UP |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | ZNF512B PRKD3 SIK2 IL17RA ABHD14A NDST2 RGS3 NCOR1 LIG3 OASL CBX8 | 1.16e-05 | 196 | 250 | 11 | 7448_DN |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HT_HG-U133A | ZNF219 PDGFRB CEACAM6 CUL9 ZCCHC14 STRA6 COL7A1 PCDHA5 ARHGEF40 ARHGAP33 HR | 1.22e-05 | 197 | 250 | 11 | 6705_UP |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | CYP3A5 SPEG SPTBN5 ZMIZ2 SIK2 ADAMTS13 ADAM12 TGM2 ARHGEF10 MMRN2 HR | 1.22e-05 | 197 | 250 | 11 | 6096_UP |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; HL60; HT_HG-U133A | CYP3A5 CUL7 SPTBN5 ZMIZ2 CLN6 PCBP4 DAGLA FN1 ZDHHC14 CDC14A ARHGAP33 | 1.28e-05 | 198 | 250 | 11 | 2999_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | PSG1 IKZF1 CASKIN2 ZMIZ2 IL17RA STRA6 DOK1 COL7A1 RGS3 SNAPC4 TMC5 | 1.34e-05 | 199 | 250 | 11 | 1536_DN |
| Drug | kalinin | 3.05e-05 | 55 | 250 | 6 | CID000032518 | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; HL60; HT_HG-U133A | PATZ1 IKZF1 ZNF395 PTCH1 GFI1 IL17RA TACC3 PRRC2B PTPN18 ARHGEF40 | 3.66e-05 | 183 | 250 | 10 | 1304_DN |
| Drug | R245fa | 4.43e-05 | 7 | 250 | 3 | CID000068030 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | GPR137 SOCS6 PCDH17 ZCCHC14 ZMIZ2 DAGLA HSPG2 ELOA EDEM3 TGM2 | 5.03e-05 | 190 | 250 | 10 | 4362_DN |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | GPR137 PTPRN2 ZMIZ2 NID1 DLX4 DNAH3 ZDHHC14 PTPN18 ARHGAP6 OASL | 5.49e-05 | 192 | 250 | 10 | 7526_UP |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | PRKD3 PLXNA1 PRRC2B ELOA NDST2 ARHGEF10 WDR6 SMARCA2 SMARCC2 SNAPC4 | 5.73e-05 | 193 | 250 | 10 | 1749_DN |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A | IRF2BP1 IKZF1 SOCS6 PTCH1 PTPRN2 IL17RA COL7A1 PCDHA5 TGM2 ARHGEF10 | 5.73e-05 | 193 | 250 | 10 | 6734_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 5.73e-05 | 193 | 250 | 10 | 4338_DN | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A | GPR137 CEACAM5 HPSE2 CUL7 GFI1 SPTBN5 CASKIN2 ZMIZ2 CLN6 ARHGAP33 | 5.99e-05 | 194 | 250 | 10 | 4223_UP |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.25e-05 | 195 | 250 | 10 | 4792_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 6.25e-05 | 195 | 250 | 10 | 4360_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HT_HG-U133A | PATZ1 CUL7 RUSC2 ZMIZ2 PXN DNAH3 FRMPD1 ARHGAP6 LIG3 ARHGEF10 | 6.53e-05 | 196 | 250 | 10 | 4656_DN |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.53e-05 | 196 | 250 | 10 | 6785_UP | |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A | ZNF219 LAMC3 RUSC2 ZMIZ2 CLN6 COL7A1 PTPN18 FAAP100 CDC14A SNAPC4 | 6.81e-05 | 197 | 250 | 10 | 1803_DN |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | CEACAM5 SPIB CYP3A5 CUL9 GPR162 DLEC1 HSPG2 COL7A1 TEX13A ADAM12 | 6.81e-05 | 197 | 250 | 10 | 4143_UP |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | IRF2BP1 SPTBN5 PXN EPS8L3 TAL1 HSPG2 COL9A1 RGS3 LZTS1 PRDM14 | 6.81e-05 | 197 | 250 | 10 | 4305_UP |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | LAMC3 ZCCHC14 AEBP1 ZMIZ2 SIK2 IL17RA STRA6 DAGLA ZDHHC14 CBX8 | 6.81e-05 | 197 | 250 | 10 | 3463_UP |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; PC3; HT_HG-U133A | CYP3A5 RUSC2 PTPRN2 DNAH3 POLH PTPN18 FAAP100 ARHGAP6 OASL SNAPC4 | 6.81e-05 | 197 | 250 | 10 | 6694_DN |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | HDAC9 PDGFRB CUL9 PTCH1 PKP2 TRAPPC9 SEMA6C ARHGEF40 RIMBP2 FUT5 | 6.81e-05 | 197 | 250 | 10 | 3616_UP |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | GPR137 MBNL1 PRKD3 ZMIZ2 PXN HSPG2 ZDHHC14 EDEM3 SMARCA2 ARHGAP33 | 6.81e-05 | 197 | 250 | 10 | 4363_DN |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | IRF2BP1 IKZF1 DAGLA COL7A1 ZDHHC14 C11orf16 TGM2 SMARCA2 PAWR CDH8 | 7.10e-05 | 198 | 250 | 10 | 3433_UP |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A | 7.10e-05 | 198 | 250 | 10 | 3676_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | GPR137 SOCS6 PTPRN2 STRA6 FN1 CDC14A SMARCA2 MMRN2 PRDM14 ARHGAP33 | 7.10e-05 | 198 | 250 | 10 | 4562_UP |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 7.10e-05 | 198 | 250 | 10 | 6473_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; PC3; HT_HG-U133A | CEACAM6 SOCS6 PTCH1 RUSC2 PTPRN2 ZMIZ2 IL17RA PLXNA1 HSPG2 PTPN18 | 7.10e-05 | 198 | 250 | 10 | 6685_DN |
| Drug | Rgd Peptide | 7.19e-05 | 239 | 250 | 11 | CID000104802 | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; PC3; HT_HG-U133A | ZNF219 LAMC3 CUL7 COL7A1 FRMPD1 PTPN18 FAAP100 LIG3 ARHGEF10 SNAPC4 | 7.41e-05 | 199 | 250 | 10 | 4668_DN |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | KMT2B ZNF512B CASKIN2 IL17RA FN1 SCYL3 LAMA5 LIG3 OASL SMARCA2 | 7.41e-05 | 199 | 250 | 10 | 7436_DN |
| Drug | gold nanoparticles | CEACAM5 CEACAM8 CEACAM6 ADCY8 PRKD3 NID1 COL7A1 ADCY4 COL9A1 POLH AQP7 | 8.34e-05 | 243 | 250 | 11 | CID000023985 |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 9.09e-05 | 165 | 250 | 9 | 5227_UP | |
| Disease | Colorectal Carcinoma | ADCY8 PTPRN2 SCNN1G ADAMTS18 NID1 UGT3A2 COL7A1 DNAH3 FN1 ABCB6 CDC14A PTPRT TGM2 LIG3 DCHS1 MMRN2 MTRR ZSCAN16 IGSF21 HR | 1.73e-06 | 702 | 243 | 20 | C0009402 |
| Disease | serum carcinoembryonic antigen measurement | 1.96e-05 | 20 | 243 | 4 | EFO_0005760 | |
| Disease | C-reactive protein measurement | MBNL1 IL22RA1 ADCY8 PCDH17 ZNF469 CILP2 ZMIZ2 PCDH15 PXN NID1 ASCL4 DAGLA SEMA6C HYKK NDST2 CIT MADD NCOR1 RADIL OASL SMARCC2 TNFRSF1A SNAPC4 TRIB1 ARHGAP33 | 2.37e-05 | 1206 | 243 | 25 | EFO_0004458 |
| Disease | cortical thickness | VWA5B2 HDAC9 PALD1 KMT2B PSG1 CUL9 LAMC3 PTCH1 PCDH17 KLHL29 ZNF469 ADAMTS18 DLEC1 TACC3 PLEKHA7 GPBAR1 HSPG2 FZD3 ADAM12 CELSR1 ARHGEF40 PCDHGB4 CBX8 | 5.33e-05 | 1113 | 243 | 23 | EFO_0004840 |
| Disease | Marie Unna congenital hypotrichosis | 6.75e-05 | 2 | 243 | 2 | C2931059 | |
| Disease | obsolete_red blood cell distribution width | KMT2B IRF2BP1 PSG1 BCAS3 PATZ1 MIDEAS GFI1 CILP2 NFE2L1 FBXO7 HERC1 TAL1 DAGLA SLC23A1 TRAPPC9 DCAF12 EP400 ZDHHC14 ABCB6 CIT PARP10 SMARCA2 LRRC37B TRIB1 SLC22A31 | 1.38e-04 | 1347 | 243 | 25 | EFO_0005192 |
| Disease | lymphocyte count | HDAC9 PALD1 PSG1 CYP3A5 BCAS3 MBNL1 INSRR IKZF1 PGLYRP2 ZNF395 KLHL29 ZNF469 CILP2 CORO7 MEX3B DCAF12 FN1 PCDHGC4 PCDHGB6 ADRM1 PTPRT NCOR1 PRF1 PCDHGB4 TNFRSF1A TRIB1 | 2.02e-04 | 1464 | 243 | 26 | EFO_0004587 |
| Disease | Myopia | 2.33e-04 | 15 | 243 | 3 | C0027092 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.85e-04 | 16 | 243 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.85e-04 | 16 | 243 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.85e-04 | 16 | 243 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.85e-04 | 16 | 243 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.85e-04 | 16 | 243 | 3 | C0025237 | |
| Disease | Van Buchem disease | 3.44e-04 | 17 | 243 | 3 | C0432272 | |
| Disease | level of chitinase-3-like protein 1 in blood serum | 4.01e-04 | 4 | 243 | 2 | OBA_2041005 | |
| Disease | cD177 antigen measurement | 4.11e-04 | 18 | 243 | 3 | EFO_0021866 | |
| Disease | diastolic blood pressure, systolic blood pressure | HDAC9 HDAC4 PSG1 SPEG MBNL1 ZNF512B MRC2 DLEC1 TAL1 TRAPPC9 RANBP9 CBLB KIAA1671 LIG3 MMRN2 | 4.84e-04 | 670 | 243 | 15 | EFO_0006335, EFO_0006336 |
| Disease | Osteochondrodysplasias | 4.85e-04 | 19 | 243 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 4.85e-04 | 19 | 243 | 3 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 5.67e-04 | 20 | 243 | 3 | C0026760 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 6.06e-04 | 47 | 243 | 4 | DOID:9074 (is_marker_for) | |
| Disease | serum iron measurement | 7.36e-04 | 86 | 243 | 5 | EFO_0006332 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 7.68e-04 | 50 | 243 | 4 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 8.91e-04 | 52 | 243 | 4 | C0023452 | |
| Disease | neutrophil-to-lymphocyte ratio | 8.94e-04 | 185 | 243 | 7 | EFO_0008447 | |
| Disease | N-acetylalanine measurement | 9.91e-04 | 6 | 243 | 2 | EFO_0800118 | |
| Disease | extraversion measurement | 9.91e-04 | 6 | 243 | 2 | EFO_0007913 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.10e-03 | 55 | 243 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | congenital disorder of glycosylation type II (is_implicated_in) | 1.38e-03 | 7 | 243 | 2 | DOID:0050571 (is_implicated_in) | |
| Disease | Severe congenital neutropenia | 1.38e-03 | 7 | 243 | 2 | cv:C1853118 | |
| Disease | Angle Closure Glaucoma | 1.38e-03 | 7 | 243 | 2 | C0017605 | |
| Disease | transforming growth factor beta measurement | 1.39e-03 | 27 | 243 | 3 | EFO_0004818 | |
| Disease | stimulant use measurement | 1.55e-03 | 28 | 243 | 3 | EFO_0600076 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.62e-03 | 61 | 243 | 4 | C1961102 | |
| Disease | Microphthalmia associated with colobomatous cyst | 1.83e-03 | 8 | 243 | 2 | C2931501 | |
| Disease | Epstein-Barr virus infection | 2.17e-03 | 66 | 243 | 4 | EFO_0000769 | |
| Disease | Glioblastoma Multiforme | 2.29e-03 | 111 | 243 | 5 | C1621958 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.34e-03 | 9 | 243 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Pulmonary Cystic Fibrosis | 2.34e-03 | 9 | 243 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 2.34e-03 | 9 | 243 | 2 | C1527396 | |
| Disease | insulin response measurement | 2.34e-03 | 9 | 243 | 2 | EFO_0008473 | |
| Disease | Brain Tumor, Primary | 2.51e-03 | 33 | 243 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 2.51e-03 | 33 | 243 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 2.51e-03 | 33 | 243 | 3 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 2.51e-03 | 33 | 243 | 3 | C0496899 | |
| Disease | Neoplasms, Intracranial | 2.51e-03 | 33 | 243 | 3 | C1527390 | |
| Disease | myocardial infarction | 2.61e-03 | 350 | 243 | 9 | EFO_0000612 | |
| Disease | lymphocyte:monocyte ratio | 2.80e-03 | 288 | 243 | 8 | EFO_0600088 | |
| Disease | Cleft palate | 2.83e-03 | 71 | 243 | 4 | HP_0000175 | |
| Disease | Schizophrenia | HDAC9 HDAC4 PDGFRB CYP3A5 MBNL1 CSMD2 PCDH17 TAP1 CACNA1B FZD3 RANBP9 ADAM12 TGM2 SMARCA2 PAWR TNFRSF1A | 2.84e-03 | 883 | 243 | 16 | C0036341 |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 2.91e-03 | 10 | 243 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 2.91e-03 | 10 | 243 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.29e-03 | 74 | 243 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Microphthalmos | 3.54e-03 | 11 | 243 | 2 | C0026010 | |
| Disease | Cystic Fibrosis | 3.54e-03 | 11 | 243 | 2 | C0010674 | |
| Disease | Malignant neoplasm of brain | 3.76e-03 | 38 | 243 | 3 | C0153633 | |
| Disease | retinal vasculature measurement | PDGFRB EBF2 KLHL29 HERC2 TACC3 HSPG2 PRSS56 ZDHHC14 LZTS1 RIMBP2 PAWR | 3.95e-03 | 517 | 243 | 11 | EFO_0010554 |
| Disease | Cleft upper lip | 4.05e-03 | 39 | 243 | 3 | C0008924 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 4.05e-03 | 39 | 243 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | Brain Neoplasms | 4.05e-03 | 39 | 243 | 3 | C0006118 | |
| Disease | aspirin use measurement | 4.05e-03 | 39 | 243 | 3 | EFO_0007013 | |
| Disease | taurodeoxycholate measurement | 4.22e-03 | 12 | 243 | 2 | EFO_0010539 | |
| Disease | Congenital neutropenia | 4.22e-03 | 12 | 243 | 2 | C0340970 | |
| Disease | Coffin-Siris syndrome | 4.96e-03 | 13 | 243 | 2 | C0265338 | |
| Disease | hyperglycemia (is_marker_for) | 4.96e-03 | 13 | 243 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Giant Cell Glioblastoma | 5.17e-03 | 84 | 243 | 4 | C0334588 | |
| Disease | skin pigmentation measurement | 5.63e-03 | 137 | 243 | 5 | EFO_0007009 | |
| Disease | candidiasis (implicated_via_orthology) | 5.70e-03 | 44 | 243 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | oral cavity cancer | 5.76e-03 | 14 | 243 | 2 | EFO_0005570 | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 5.76e-03 | 14 | 243 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | pulse pressure measurement | HDAC9 PSG1 MBNL1 EBF2 PRKD3 KLHL29 CILP2 TTBK1 MRC2 DLEC1 CORO7 PLEKHA7 TRAPPC9 FN1 LAMA5 PCDHA5 MADD LIG3 DMRTA2 PAWR SLC2A11 | 5.77e-03 | 1392 | 243 | 21 | EFO_0005763 |
| Disease | beta-amyloid 1-42 measurement | 5.86e-03 | 87 | 243 | 4 | EFO_0004670 | |
| Disease | forced expiratory volume | HDAC9 HDAC4 BCAS3 PTCH1 ADCY8 KLHL29 PCDH15 TAL1 PRRC2B HYKK NCOR1 LZTS1 SMARCA2 CBX8 | 6.10e-03 | 789 | 243 | 14 | EFO_0004314 |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 6.61e-03 | 15 | 243 | 2 | C2930967 | |
| Disease | YKL40 measurement | 6.61e-03 | 15 | 243 | 2 | EFO_0004869 | |
| Disease | post-traumatic stress disorder | 6.74e-03 | 202 | 243 | 6 | EFO_0001358 | |
| Disease | granulocyte percentage of myeloid white cells | 7.02e-03 | 268 | 243 | 7 | EFO_0007997 | |
| Disease | osteoarthritis, hip | 7.12e-03 | 92 | 243 | 4 | EFO_1000786 | |
| Disease | optic disc size measurement | 7.23e-03 | 205 | 243 | 6 | EFO_0004832 | |
| Disease | vitamin C measurement | 7.51e-03 | 16 | 243 | 2 | EFO_0600003 | |
| Disease | attention function measurement | 7.75e-03 | 148 | 243 | 5 | EFO_0007636 | |
| Disease | Malignant neoplasm of breast | HDAC4 ACY1 TTC3 ZCCHC14 DLEC1 HERC2 COL7A1 FN1 PCDHGB6 POLH FRMPD1 ABCB6 ADAM12 NCOR1 TGM2 P3H2 VPS13B | 8.02e-03 | 1074 | 243 | 17 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APLYSKVTPRAQRPG | 386 | Q99952 | |
| LPPRRLPGQYSLAAV | 1181 | P40145 | |
| NGRDPPDPYVSLLLL | 1001 | Q9BSJ8 | |
| VPGISRPYLSSPLRA | 1266 | Q96L91 | |
| LSAPLQGLSEGLYPP | 56 | Q8TF63 | |
| NTPKGAARDIYLPPT | 341 | Q8NCV1 | |
| SNLPLLLPAYSSPVI | 161 | O15013 | |
| GPLLGPEAVTRIPYL | 486 | P0C7U0 | |
| ALYPPFEATAPTLLG | 16 | Q8TER5 | |
| TILSPGFPEPYLNSL | 1806 | Q7Z408 | |
| NLPIPERYLSPDATV | 726 | Q8IUX7 | |
| PEEAYRALLSGSNPP | 111 | Q9UNH5 | |
| RALLSGSNPPYLPFR | 116 | Q9UNH5 | |
| PTPLPLLGNVLSYRQ | 41 | P20815 | |
| LNVLYGPDAPTISPL | 231 | P06731 | |
| LNVLYGPDAPTISPS | 231 | P31997 | |
| YGSAVPLLTDRAPEP | 96 | Q6UWD8 | |
| ALYSVPRNPSQLPAL | 401 | Q9HAK2 | |
| RYLDLLVSSPAFPQP | 171 | Q9BQC3 | |
| GTARGAPLPSYLLLA | 96 | Q9NP58 | |
| PVRSYPGLAPGELLT | 441 | Q5JTC6 | |
| ETGLRLAPLRPAPQY | 881 | O43184 | |
| LGLYLGPQPDSRPAL | 156 | Q8NFM4 | |
| PLLPLTPAIYTGAVE | 166 | Q4G176 | |
| STLVYSEGAPLPRPL | 2376 | Q9NYQ6 | |
| GDPQRYLLPPALGLL | 486 | Q9NYJ7 | |
| IRDSISRLSNYPEPP | 2311 | Q96M86 | |
| DGYRSPLPTNESQPL | 906 | Q9H6U6 | |
| QPLAPGSRIGSDPYL | 2246 | Q00975 | |
| LAAANGIIPPRPAYE | 141 | Q96SC8 | |
| LAPVPSVAAAYPLGL | 21 | Q92988 | |
| LDIPNPRYLGPAISS | 1866 | O14578 | |
| LEPQAVSSYLSPGAP | 41 | Q76LX8 | |
| NRPERLYAPGPTNET | 826 | Q8TE60 | |
| LRPPGYSRLPAAKLA | 836 | Q5JR59 | |
| LPPLREIILGPSSAY | 36 | Q14494 | |
| LGIAFTDLPPNLYPT | 301 | Q96S59 | |
| LLDPGSSYLLQEPPR | 206 | Q96IZ0 | |
| PSYLVELPENAPLGT | 246 | O14917 | |
| LLYLGGVEPSVPLSP | 4051 | P98160 | |
| LLDPEPPRYLQSLSG | 16 | Q8WWW0 | |
| LAPLNPGSQLLRPVY | 471 | P49796 | |
| AYTPELGLVPRSSPQ | 826 | Q9H3S7 | |
| PAAYTVPSLLGPRVI | 141 | A8MYP8 | |
| APPGEGSLEPQYLLR | 256 | Q92932 | |
| EYRISLSENLPPGSP | 246 | Q9Y5F9 | |
| NAPRVLYPALGPDGS | 556 | Q9UN71 | |
| YRLPVTLSSAGPVAP | 461 | Q9ULE6 | |
| QYITVSPPGLPREAL | 176 | Q9HCM3 | |
| PGLYIQTLLPGSPAA | 1001 | Q96JH8 | |
| LLLYVGLPGPPEQTS | 46 | Q9BUJ0 | |
| LRQELSLPYLPSGTP | 381 | Q13231 | |
| PRGRTPPNLLSTLQY | 931 | Q5VWQ8 | |
| APPGLLGTPYAISLS | 341 | P57723 | |
| NASILYRLAGTPPPG | 1996 | Q96JQ0 | |
| AAVVDSAPRPLQPYL | 61 | Q96H96 | |
| VAINSPGLLYPAELP | 281 | O60320 | |
| YISRSSPQPPEGLTE | 796 | Q96F46 | |
| LPGLPSLSYPRRDNV | 36 | P31275 | |
| YTSPSLPNITLGLPA | 346 | P56524 | |
| LLLAPTPYIIGVPAS | 366 | Q8WXG6 | |
| YQLDPLVTPVGPTSR | 191 | Q9Y250 | |
| PTTLLNGELRPYHTP | 686 | Q9BY89 | |
| HQPRSPGPDYSLRLE | 16 | Q99684 | |
| VLPAQSRALGGPPEY | 441 | Q16538 | |
| GQADPSLAPYIIDLP | 66 | Q86UW9 | |
| LSVLAYEQRPPLGPG | 246 | Q8TDU6 | |
| YEQRPPLGPGTLLSL | 251 | Q8TDU6 | |
| PLSPNESFLRYLTLP | 366 | O95714 | |
| TPGPLPLSYEQIRVA | 626 | Q9H8L6 | |
| PALPPAVTLGLTAAY | 16 | Q96N19 | |
| TGYAINPSRDLPPRI | 221 | A6NL99 | |
| LNVLYGPDVPTISPS | 231 | P40199 | |
| SVPPGYEPISLLEAL | 381 | O60291 | |
| SQASLNIPGLPPEYL | 236 | Q9UBK8 | |
| LPAFNTTSGLPYPRI | 191 | Q9BZQ6 | |
| LGLPDTVPPQYGALR | 4376 | Q15751 | |
| GRAPLAPPYAVVLIS | 31 | Q96Q04 | |
| YLRAQRPPEGLSPEL | 221 | Q96Q04 | |
| NRTPSDYDLLIPPLG | 796 | Q13191 | |
| GLDVAPSTLLPSYDP | 726 | P57737 | |
| LASYLPPGLALRPLE | 971 | O43593 | |
| LLPPAPGNSRLNYTV | 1176 | Q9UIW2 | |
| VYLRPPAIPAATQDL | 256 | Q8NHC7 | |
| TLQPLEVAEGSPLYP | 21 | P23409 | |
| SLPGSPGLVDYTLEP | 331 | P14222 | |
| ILGDYLSRTPEPRPS | 281 | Q96PD5 | |
| IPETVGYSLLPLAPV | 476 | P14543 | |
| SPNTPLQRLVEGYGP | 616 | Q14999 | |
| AGYPSLLRPTPTLTL | 11 | A6NMT0 | |
| SGYIPSNILEPLQPG | 496 | Q8TE67 | |
| SPYQPPTLASLQRLL | 21 | Q9UII6 | |
| GLSVPRPLQPEYVAL | 221 | O94806 | |
| APAYLSSPLALPSQR | 371 | Q9Y6K9 | |
| ALPPAPGTELSYLNG | 1121 | Q9UBG0 | |
| TLYPGSLPPELRVNA | 231 | Q96QE4 | |
| ESLQTGDYPIPLSRP | 301 | Q7L4E1 | |
| GPQPRVYTISGEPAL | 96 | Q6X4W1 | |
| KVPNYSPSRRPLGGV | 1866 | Q9UMN6 | |
| TGYAINPSRDLPPRI | 221 | O14520 | |
| RSNYPPPLSSAALRG | 221 | Q8N319 | |
| RGGLTLNEPLSPLYP | 341 | A6NEQ2 | |
| PLLAAAAGAPAPLYL | 3631 | O15230 | |
| YLGAESLRPLVQTPP | 321 | Q13422 | |
| LEPGPLQPFDLLYAS | 36 | Q8IVL5 | |
| RPSCPPSDLLYGLEQ | 801 | Q9Y5F7 | |
| LSYELQPAPGSARIP | 606 | Q9Y5H7 | |
| DIFTGVRLYLPPSTP | 936 | P49916 | |
| SRPPACLAPGALYLA | 16 | Q8WWQ2 | |
| AGPASLRAEYLPPSV | 691 | Q0VG06 | |
| TAGPSEALQPLVYPL | 421 | Q9Y3T9 | |
| PLTYSQLPRVGLSPD | 381 | Q8WXE0 | |
| VTIVPAYRALGPSLP | 151 | Q15646 | |
| AYRALGPSLPNSQPP | 156 | Q15646 | |
| PIAPPELLAVGATYL | 291 | O14522 | |
| VTSLQLGYIDLPPPR | 316 | Q9HBE1 | |
| ALSPLYGVPETNSPL | 176 | P49023 | |
| YTLREPPFTLPSGLA | 11 | Q8IZE3 | |
| LPGPAASQLRYSVPE | 36 | Q9Y5I4 | |
| YSPSLPAESLGPRLA | 66 | O43182 | |
| RSYPITPLGSAEAIP | 726 | Q96JP2 | |
| RNIQPPSDRPGILYS | 311 | Q96QU1 | |
| EPLYVNLALGPRGPS | 1166 | O14559 | |
| LALPPGSVISYPLEN | 86 | O75787 | |
| LARGYLTVNIEPLPP | 21 | Q96ID5 | |
| LTYLPGRPIAELPVS | 126 | A2RU49 | |
| GRPIAELPVSPQLLY | 131 | A2RU49 | |
| LQLASLPLLPESPRY | 201 | Q9BYW1 | |
| GIRIPYPGRSPQDLA | 101 | Q9HC52 | |
| SPPALYAEPLDSLRI | 291 | Q99704 | |
| SGPTIQDYLNRPRPT | 26 | Q5BKY9 | |
| LLTGGIALDNPYPNP | 3396 | Q8TD57 | |
| YRPLPSLELISSFQP | 521 | Q14241 | |
| VAEALYSTPRAPGPL | 401 | Q9BQW3 | |
| NPNSLAIYRLPTLDP | 161 | Q5T6F0 | |
| RPTLPYVGDPISSLI | 451 | Q9Y3I1 | |
| PPSIDLTNFLVRYSP | 1381 | P02751 | |
| REPYLALGAPSPTVS | 871 | Q5SYB0 | |
| AAARSIPPIYGPLQE | 141 | A6NJJ6 | |
| SPYPEAVELQRRSLP | 61 | Q9H6R0 | |
| YLGPVSPSLVPAEIL | 136 | Q9NR56 | |
| PPSSLALLNSVVYGP | 66 | Q6PJG2 | |
| ILLELTYQGPPVPAS | 16 | Q6UXX5 | |
| AQSPIVYLRTLPAAP | 591 | P14616 | |
| ALPYSLRTAPLGVPG | 11 | Q6XD76 | |
| IALSASTPLYPPGRI | 591 | Q9Y4D2 | |
| PYPRLVDLNLAGEPT | 136 | Q9NPG1 | |
| PPRYLLLSAPAYAGA | 266 | Q9NU39 | |
| LSPLSYAPNAAPEVG | 346 | Q8N6P7 | |
| PPYTGDLSLAPRISG | 196 | Q4VXA5 | |
| SIFQPYISGPSLLLP | 336 | Q8IWT3 | |
| RIPTRNLYPSGLPEE | 96 | P20849 | |
| YTPLTGLGQPLPSER | 266 | Q02388 | |
| VYLLPIIISDSGNPP | 571 | P55286 | |
| PGYGPIISSLPQLLS | 206 | O43809 | |
| YSLPGALPISGQPLT | 1056 | A6NE01 | |
| LYTSPSLPNITLGLP | 321 | Q9UKV0 | |
| PLQPGSATGIAYDPL | 626 | Q9UKV0 | |
| LRVLPPSTPYFALGL | 406 | Q9Y238 | |
| SDPVTLNVLYGPDLP | 321 | Q00888 | |
| ARSPQPRYHSPLGLL | 316 | A6NKX4 | |
| GTPPPKYNTLRLERA | 621 | P51170 | |
| GTLLRLAGPPIPYTA | 211 | P0C263 | |
| PRTPLYLQPDAYGSL | 121 | Q8WUF5 | |
| FDPLIGSPYLAALAP | 111 | Q8N813 | |
| ELTPTPGGLALVSPY | 31 | Q9BV19 | |
| LPLPSPALEYTLGSR | 121 | Q8IU81 | |
| SDPVTLNVLYGPDLP | 321 | P11464 | |
| PSAELYSNALPVGLP | 711 | P09619 | |
| PLYTRLPPSALQVLS | 21 | P0CW18 | |
| RGLPPAVPDELLTLY | 16 | Q53GL7 | |
| YASLQRLPVPSSEGP | 56 | O00453 | |
| ATQRLADYSPPSPAL | 311 | Q6ZN04 | |
| SLLVPAPLSGPRRYQ | 366 | Q8ND04 | |
| VLGPSRSNYERFLPP | 286 | Q11128 | |
| PDSGLVPLAYVTLTP | 1491 | Q8N2Y8 | |
| SSAIGEYIRPLPQPG | 111 | O15034 | |
| PPLSTGPIVDLLQYS | 626 | Q9Y6A5 | |
| RHTSGALYAPLLPLP | 236 | Q7Z736 | |
| LVNYNRPSGPGPELS | 256 | P51531 | |
| PLLSPGLGLQREPLY | 76 | Q9GZV8 | |
| SYTLDLGESQLAPPP | 321 | Q9ULQ0 | |
| ANPRLGLPALLNSYP | 211 | Q69YZ2 | |
| GPQASPVLPVSYRLS | 36 | Q6IEE7 | |
| LPQIPSNLYGSPGSI | 216 | Q8N5C8 | |
| LSQLAYGPAVPPQTL | 226 | Q8WV15 | |
| RPVAAPNNSLLSGYP | 61 | A6NJ46 | |
| PYLVSPPIAGRLVDT | 421 | Q6ZSM3 | |
| ALLGLRCPLYPSFPE | 1121 | Q58EX7 | |
| LDPTVLPLYSLGPSG | 446 | O94761 | |
| LAAPAAPGRALLYSL | 126 | P17542 | |
| PLGLPYPATRGIIDL | 1641 | O75376 | |
| AASPPLYSQVPDRLV | 256 | Q13461 | |
| LGSIPLPSYVISPVA | 206 | Q6IQ23 | |
| YPEVSPANGLNRLPT | 1181 | Q13635 | |
| PGLQEAPSSYDPLAL | 886 | Q9H0K1 | |
| YLDRTPRCPPSGLLT | 481 | Q03518 | |
| LLPSTYIEGLPQGPT | 141 | Q9Y253 | |
| NRYASGPLLPTLTAP | 446 | Q9H6T0 | |
| SLLRPTDGPEYSPTQ | 506 | A8MXQ7 | |
| SDPVTLNVLYGPDLP | 321 | Q13046 | |
| PTYSPAGNLELAPSL | 81 | Q01892 | |
| LITYPVPGNDDSPLA | 231 | Q9Y399 | |
| DSEASLGPLAYQPIP | 651 | Q8TAQ2 | |
| PDLLDYGSLRPDRPL | 221 | Q9NRC6 | |
| LLPPRAATLDPGYYT | 551 | Q9BX79 | |
| LPYLPSGESLPQTAD | 311 | Q16186 | |
| YTRLLPALASVPALP | 391 | Q03154 | |
| IPGPALLLVAPSGLY | 206 | Q9NWW5 | |
| RPLPATVGVTQPYLD | 826 | Q8IUL8 | |
| DVIPLSPSVGYSLRP | 141 | Q9NQ32 | |
| TPLINPLAGRAPYVG | 246 | Q9NZN8 | |
| TPANAPIGLYRLSLE | 106 | P21980 | |
| PVTLGASLRPLCLPY | 391 | Q2L4Q9 | |
| PSPPYLGLLLAATGN | 536 | Q9NRF8 | |
| GLSLSPQSPPERRGY | 1426 | Q7Z2Z1 | |
| EVNGLPRAVPLSLPY | 671 | Q5TCY1 | |
| PGPSRIADYLLLPLA | 86 | Q96RU8 | |
| GALELLSPQPLFPYA | 231 | Q8WVN6 | |
| GIYRPSPAGTPLELV | 2371 | Q15772 | |
| GNLSLPIPIYGNSPL | 331 | P60508 | |
| PGALLNYIGPLTVTP | 176 | Q9UHI7 | |
| QVPAAYPGILSLEAP | 1086 | Q9UPX0 | |
| GLQPYPEILVVSRSP | 516 | O43353 | |
| VPSYLPDLPGIANDL | 246 | Q6VEQ5 | |
| VPSYLPDLPGIANDL | 246 | A8K0Z3 | |
| PLEPGAQALAYRPVS | 136 | Q9H8N7 | |
| PLASLSPEYQLPRSV | 1351 | P53804 | |
| TYEPVLLASLRPAEP | 236 | P52849 | |
| PRDLSAIYEAIPLSP | 86 | Q8TCT1 | |
| ALLGLYPALCSPRVP | 616 | C9JH25 | |
| LDLSYGPGPSLRPQN | 191 | Q5JSZ5 | |
| ASDAVVYRSLGPQPP | 196 | Q9H3T2 | |
| VYRSLGPQPPLRSAK | 201 | Q9H3T2 | |
| PALLTRVPSGGPSRY | 861 | Q9H3T2 | |
| LYPYLGPSTLRDRPQ | 486 | Q9NRW7 | |
| VDPGLPYRLGTPSLT | 961 | Q9NNW5 | |
| PSLIDRRGYIQPDTP | 321 | Q8IZN3 | |
| TNPDELLSYLGPPDL | 891 | Q8NF64 | |
| LPVDRFDPPLYGSLS | 1431 | Q96JG9 | |
| IPLLSGLSRAAYPPE | 176 | P58753 | |
| VPETARLNYTRPGLP | 716 | Q96KM6 | |
| PPAIINPRTALYTAN | 666 | Q8WYQ9 | |
| LTPREIPALYPGDQL | 541 | Q8N398 | |
| PLGRPYESLTVQLHP | 146 | Q9H4T2 | |
| IPIRLFLAGYDPTPT | 246 | O75436 | |
| RASSEPLPVQLPASY | 286 | Q9BXU3 | |
| TDPDLPPGYVQSLIR | 131 | Q7Z7G8 | |
| LLGSRLPYQPPALCS | 1296 | Q5SXM2 | |
| LNCSRTRPDAPGLPY | 331 | P35713 | |
| PAALSLPAESGLYPV | 631 | Q96Q05 | |
| PGSLAEPNYPRSLSN | 66 | Q6UXY8 | |
| SQPYTRGLPLDESPA | 856 | Q5QJ38 | |
| GLPIPLSYVPVFRSL | 176 | Q3SY77 | |
| SAYGPPTRAVSILPL | 171 | Q9Y2W2 | |
| PPYQGADPILATALA | 316 | P19438 | |
| FDSIPANPALLTYPR | 231 | Q99959 | |
| ANPALLTYPRPGTSR | 236 | Q99959 | |
| RLPGSATYPVRLTNP | 476 | O14544 | |
| GNLPRIFDYSPLDPT | 366 | Q92995 | |
| ARAPQPPDLGLLAYE | 341 | Q9P2Y4 | |
| TPVLDPARRQGYGPL | 186 | Q06643 | |
| LYASPQPLAVSTLPG | 226 | Q96CT2 | |
| TAPYLALLASPGALP | 1246 | Q9Y6N6 |